Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Number of Patients with Antiproliferative Effects of Arimidex
Biomarker modulation study on effects of Armimidex in ductal lavage fluid from evaluable epithelial cells specimen.
Study duration 4 years
No
Banu Arun, MD
Study Chair
UT MD Anderson Cancer Center
United States: Institutional Review Board
LAB02-0400
NCT01207635
November 2002
January 2006
Name | Location |
---|---|
UT MD Anderson Cancer Center | Houston, Texas 77030 |